Feedback / Questions
STRO-004 - Sutro Biopharma
https://www.globenewswire.com/news-release/2025/12/03/3198799/0/en/Sutro-Biopharma-Announces-First-Cohort-of-Patients-Dosed-in-Phase-1-Trial-of-STRO-004-a-Next-Generation-Tissue-Factor-ADC-in-TF-Expressing-Solid-Tumors.html
Dec 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next